221 related articles for article (PubMed ID: 36220780)
1. Recent Advances of Anticancer Studies Based on Nano-Fluorescent Metal-Organic Frameworks.
Liang R; Liu N; Li F
ChemMedChem; 2022 Dec; 17(24):e202200480. PubMed ID: 36220780
[TBL] [Abstract][Full Text] [Related]
2. Drug carrier wonders: Synthetic strategies of zeolitic imidazolates frameworks (ZIFs) and their applications in drug delivery and anti-cancer activity.
Akhtar H; Amara U; Mahmood K; Hanif M; Khalid M; Qadir S; Peng Q; Safdar M; Amjad M; Saif MZ; Tahir A; Yaqub M; Khalid K
Adv Colloid Interface Sci; 2024 Jul; 329():103184. PubMed ID: 38781826
[TBL] [Abstract][Full Text] [Related]
3. Recent Advances in Metal-Organic Frameworks as Anticancer Drug Delivery Systems: A Review.
Karami A; Mohamed O; Ahmed A; Husseini GA; Sabouni R
Anticancer Agents Med Chem; 2021; 21(18):2487-2504. PubMed ID: 33463479
[TBL] [Abstract][Full Text] [Related]
4. Stimuli-Responsive Design of Metal-Organic Frameworks for Cancer Theranostics: Current Challenges and Future Perspective.
Pantwalawalkar J; Mhettar P; Nangare S; Mali R; Ghule A; Patil P; Mohite S; More H; Jadhav N
ACS Biomater Sci Eng; 2023 Aug; 9(8):4497-4526. PubMed ID: 37526605
[TBL] [Abstract][Full Text] [Related]
5. Advances in antitumor nanomedicine based on functional metal-organic frameworks beyond drug carriers.
Wei Q; Wu Y; Liu F; Cao J; Liu J
J Mater Chem B; 2022 Feb; 10(5):676-699. PubMed ID: 35043825
[TBL] [Abstract][Full Text] [Related]
6. Metal organic frameworks (MOFs) with therapeutic and biomedical applications: a patent review.
Teixeira de Alencar Filho JM; Sampaio PA; Silva de Carvalho I; Rocha da Silva A; Pereira ECV; Araujo E Amariz I; Nishimura RHV; Cavalcante da Cruz Araújo E; Rolim-Neto PJ; Rolim LA
Expert Opin Ther Pat; 2021 Oct; 31(10):937-949. PubMed ID: 33915072
[No Abstract] [Full Text] [Related]
7. Copper-based metal-organic frameworks for biomedical applications.
Cun JE; Fan X; Pan Q; Gao W; Luo K; He B; Pu Y
Adv Colloid Interface Sci; 2022 Jul; 305():102686. PubMed ID: 35523098
[TBL] [Abstract][Full Text] [Related]
8. Metal-Organic Framework (MOF)-A Universal Material for Biomedicine.
Vodyashkin AA; Sergorodceva AV; Kezimana P; Stanishevskiy YM
Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175523
[TBL] [Abstract][Full Text] [Related]
9. Theranostics of metal-organic frameworks: image-guided nanomedicine for clinical translation.
Mehata AK; Vikas ; Viswanadh MK; Muthu MS
Nanomedicine (Lond); 2023 Apr; 18(8):695-703. PubMed ID: 37259854
[TBL] [Abstract][Full Text] [Related]
10. State-of-the-art progress of switch fluorescence biosensors based on metal-organic frameworks and nucleic acids.
Huo YP; Liu S; Gao ZX; Ning BA; Wang Y
Mikrochim Acta; 2021 Apr; 188(5):168. PubMed ID: 33884514
[TBL] [Abstract][Full Text] [Related]
11. Recent advances in Cu(II)/Cu(I)-MOFs based nano-platforms for developing new nano-medicines.
Sun Y; Jiang X; Liu Y; Liu D; Chen C; Lu C; Zhuang S; Kumar A; Liu J
J Inorg Biochem; 2021 Dec; 225():111599. PubMed ID: 34507123
[TBL] [Abstract][Full Text] [Related]
12. Nanoporous metal organic frameworks as hybrid polymer-metal composites for drug delivery and biomedical applications.
Beg S; Rahman M; Jain A; Saini S; Midoux P; Pichon C; Ahmad FJ; Akhter S
Drug Discov Today; 2017 Apr; 22(4):625-637. PubMed ID: 27742533
[TBL] [Abstract][Full Text] [Related]
13. Current and emerging applications of nanostructured metal-organic frameworks in cancer-targeted theranostics.
Lakshmi BA; Kim S
Mater Sci Eng C Mater Biol Appl; 2019 Dec; 105():110091. PubMed ID: 31546428
[TBL] [Abstract][Full Text] [Related]
14. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
[TBL] [Abstract][Full Text] [Related]
15. Metal-Organic Framework-Based Nanomedicines for Ferroptotic Cancer Therapy.
Song Y; Xu X; Wang Z; Zhao Y
Adv Healthc Mater; 2024 Apr; 13(11):e2303533. PubMed ID: 38221753
[TBL] [Abstract][Full Text] [Related]
16. Nanoscaled Metal-Organic Frameworks for Biosensing, Imaging, and Cancer Therapy.
Zhou J; Tian G; Zeng L; Song X; Bian XW
Adv Healthc Mater; 2018 May; 7(10):e1800022. PubMed ID: 29508557
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in Metal-Organic Frameworks as nanocarriers for triggered release of anticancer drugs: Brief history, biomedical applications, challenges and future perspective.
Fatima SF; Sabouni R; Garg R; Gomaa H
Colloids Surf B Biointerfaces; 2023 May; 225():113266. PubMed ID: 36947901
[TBL] [Abstract][Full Text] [Related]
18. Trend in biodegradable porous nanomaterials for anticancer drug delivery.
Le BQG; Doan TLH
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2023; 15(4):e1874. PubMed ID: 36597015
[TBL] [Abstract][Full Text] [Related]
19. Metal-Organic Frameworks for Drug Delivery: A Design Perspective.
Lawson HD; Walton SP; Chan C
ACS Appl Mater Interfaces; 2021 Feb; 13(6):7004-7020. PubMed ID: 33554591
[TBL] [Abstract][Full Text] [Related]
20. Applications of nanoscale metal-organic frameworks as imaging agents in biology and medicine.
Demir Duman F; Forgan RS
J Mater Chem B; 2021 Apr; 9(16):3423-3449. PubMed ID: 33909734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
